Condition

Latent Tuberculosis clinical trials and research

• 7Clinical trials
• 12Countries

Newest Latent Tuberculosis clinical trials

All recruiting trials (7)

• Understanding lung immune responses and microbiome after tuberculosis exposure

  This study looks at how the lungs' immune system and bacteria change in people who have recently been around someone with tuberculosis to help improve future vaccines.

  Recruiting at 3 sites University of Oxford · Oxford, Oxfordshire and 2 other locations · NCT06526689

• Evaluating drug levels in children with HIV receiving TB prevention treatment

  This study is testing how well two medications work in children with HIV who are getting treatment to prevent tuberculosis, to see if they are safe and effective for different age groups.

  Recruiting Phase 1 Brigham and Women's Hospital · Ibadan, Oyo State · NCT06281834

• One-month treatment for latent tuberculosis in school contacts

  This study is testing if a one-month treatment for latent tuberculosis can help protect school-aged kids who have been in close contact with someone who has TB.

  Recruiting at 66 sites Phase 3 Huashan Hospital · Anshun, Guiyang and 65 other locations · NCT06022146

• Examining Latent Tuberculosis Infection in Health-care Workers and Students

  This study looks at how many health care workers and students have Latent Tuberculosis Infection without symptoms and what factors might put them at risk.

  Recruiting Catholic University of the Sacred Heart · Roma · NCT05756582

• Using video therapy and financial incentives to improve treatment for latent tuberculosis

  This study is testing whether combining video therapy with financial rewards can help adults with latent tuberculosis stick to their treatment better than standard care.

  Recruiting Johns Hopkins University · Baltimore, Maryland · NCT05022862

• Comparing a 6-week rifapentine treatment for latent tuberculosis to standard longer treatments

  This study is testing if a new 6-week treatment with rifapentine can safely and effectively replace the standard 12-16 week treatment for people with latent tuberculosis.

  Recruiting at 18 sites Phase 2/3 Centers for Disease Control and Prevention · Denver, Colorado and 20 other locations · NCT03474029

• Understanding the natural history of tuberculosis

  This study is trying to learn more about tuberculosis by collecting samples and monitoring treatment in people with active or latent TB to improve how we understand and treat the disease.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT01212003

Related topics

Quick answers

How many Latent Tuberculosis clinical trials are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 12 countries. The most sites are in United States (3 trials), Italy (1 trial), Australia (1 trial), Benin (1 trial), Canada (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2/3: 1, Phase 3: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →